prototype 01
ClinicalTrials.gov-inspired scoring workflow for CTM shortlisting: input trial constraints, rank candidate sites, and inspect explainable score logic.
Score = 0.24*Experience + 0.18*Speed + 0.14*PI Capacity + 0.16*Competitor Exposure + 0.18*CTGov Relevance + 0.10*Stability + Sponsor Bonus
Sponsor Bonus = (SponsorFit - 50) * 0.12 when sponsor preference is enabled.
3
#1 Research Site
Seoul, South Korea
84.2
Tier 1
Research Site leads on PI Capacity / Execution Stability / Competitor Exposure, resulting in Tier 1 prioritization for feasibility shortlisting.
#2 Research Site
Beijing, China
82.5
Research Site leads on TA/Indication Experience / Competitor Exposure / ClinicalTrials.gov Relevance, resulting in Tier 1 prioritization for feasibility shortlisting.
#3 Research Site
Lima, Peru
62.7
Tier 3
Research Site leads on PI Capacity / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#4 Research Site
São Paulo, Brazil
61.2
#5 Research Site
Sofia, Bulgaria
55.7
Research Site leads on Site Startup Speed / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#6 Research Site
Philadelphia, United States
44.7
Research Site leads on PI Capacity / Competitor Exposure / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#7 Research Site
Athens, Greece
42.9
#8 Research Site
Montreal, Canada
40.3
#9 Research Site
Shanghai, China
39.3
#10 Research Site
Budapest, Hungary
34.4
Research Site leads on PI Capacity / Execution Stability / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#11 Research Site
London, United Kingdom
32.7
Research Site leads on PI Capacity / Sponsor Fit / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#12 Research Site
Paris, France
31.6
#13 Research Site
Houston, United States
30
#14 Research Site
Yokohama, Japan
#15 Samsung Medical Center
29.8
Samsung Medical Center leads on PI Capacity / Execution Stability / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#16 Evangelische Lungenklinik Berlin
Berlin, Germany
29.6
Evangelische Lungenklinik Berlin leads on Sponsor Fit / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#17 Research Site
Vienna, Austria
29.1
#18 Research Site
Guangzhou, China
#19 Research Site
Thessaloniki, Greece
#20 Research Site
Nagoya, Japan
28.2
Research Site leads on PI Capacity / Sponsor Fit / Competitor Exposure, resulting in Tier 3 prioritization for feasibility shortlisting.
#21 Research Site
Taipei, Taiwan
27
Research Site leads on Execution Stability / PI Capacity / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#22 Research Site
Suwon, South Korea
25.1
Research Site leads on Sponsor Fit / PI Capacity / Competitor Exposure, resulting in Tier 3 prioritization for feasibility shortlisting.
#23 Research Site
Lincoln, United States
23.8
#24 Research Site
Delhi, India
#25 Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
22.5
Hospital de la Santa Creu i Sant Pau leads on PI Capacity / Sponsor Fit / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#26 Research Site
Madrid, Spain
22.3
#27 Research Site
Hamamatsu, Japan
21.1
Research Site leads on Sponsor Fit / Competitor Exposure / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#28 Research Site
Istanbul, Turkey (Türkiye)
20.8
#29 Research Site
Taichung, Taiwan
20.7
#30 Research Site
Mexico City, Mexico
20.1
#31 St John of God Subiaco Hospital
Subiaco, Australia
18.6
St John of God Subiaco Hospital leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#32 Calvary Mater Newcastle
Waratah, Australia
Calvary Mater Newcastle leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#33 Cork University Hospital
Cork, Ireland
Cork University Hospital leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#34 Beaumont Hospital
Dublin, Ireland
Beaumont Hospital leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#35 Hospital Universitario Virgen Macarena
Seville, Spain
Hospital Universitario Virgen Macarena leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#36 Erasmus Medisch Centrum
Rotterdam, Netherlands
18.5
Erasmus Medisch Centrum leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#37 Antoni van Leeuwenhoek
Amsterdam, Netherlands
Antoni van Leeuwenhoek leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#38 Research Site
Porto Alegre, Brazil
17.6
#39 Research Site
Ankara, Turkey (Türkiye)
17.2
#40 Research Site
Stockholm, Sweden
16.7
Research Site leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#41 Research Site
San Luis Potosí City, Mexico
16
Research Site leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#42 Research Site
Bydgoszcz, Poland
#43 Research Site
Tainan, Taiwan
#44 Sir Charles Gairdner Hospital
Perth, Australia
15.9
Sir Charles Gairdner Hospital leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#45 AZ Delta
Roeselare, Belgium
AZ Delta leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#46 Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy
Fondazione IRCCS San Gerardo dei Tintori leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#47 Amsterdam UMC, Locatie VUMC
Amsterdam UMC, Locatie VUMC leads on Sponsor Fit / PI Capacity / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#48 Research Site
Kolkata, India
15
#49 Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
14.2
Fondazione IRCCS Istituto Nazionale dei Tumori leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#50 Research Site
Vitória, Brazil
#51 Research Site
Varna, Bulgaria
#52 Research Site
Montpellier, France
#53 Research Site
Toulouse, France
#54 Research Site
Arequipa, Peru
#55 Research Site
Poznan, Poland
#56 Research Site
Hamburg, Germany
12.8
#57 Princess Margaret Cancer Centre-University Health Network
Toronto, Canada
12.4
Princess Margaret Cancer Centre-University Health Network leads on Sponsor Fit / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#58 Aidport Sp. z o.o.
Skorzewo, Poland
Aidport Sp. z o.o. leads on Sponsor Fit / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#59 UMHAT "Sv. Ivan Rilski", EAD
11.8
UMHAT "Sv. Ivan Rilski", EAD leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#60 University General Hospital of Heraklion
Heraklion, Greece
11.5
University General Hospital of Heraklion leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#61 Antwerp University Hospital
Antwerp, Belgium
10.9
Antwerp University Hospital leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#62 Research Site
Newmarket, Canada
#63 Research Site
Lund, Sweden
#64 Research Site
Izmir, Turkey (Türkiye)
#65 Universitätsklinikum Köln
Cologne, Germany
10.2
Universitätsklinikum Köln leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#66 Mater Misericordiae University Hospital
Mater Misericordiae University Hospital leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#67 Research Site
Graz, Austria
#68 Research Site
Kaposvár, Hungary
#69 Research Site
Szekszárd, Hungary
#70 Research Site
Jaipur, India
#71 Research Site
Florence, Italy
#72 Research Site
México, Mexico
#73 Research Site
Aberdeen, United Kingdom
#74 Research Site
Cambridge, United Kingdom
#75 National University Hospital
Singapore, Singapore
9.8
National University Hospital leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#76 CHU de Liège
Liège, Belgium
8.2
CHU de Liège leads on Sponsor Fit / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#77 Centro de Endocrinologia y Diabetes Dr. Raul A. Gutman SRL
Buenos Aires, Argentina
7
Centro de Endocrinologia y Diabetes Dr. Raul A. Gutman SRL leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#78 Fundacion Respirar
Fundacion Respirar leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#79 Hospital Británico de Buenos Aires
Hospital Británico de Buenos Aires leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#80 Landeskrankenhaus-Universitätsklinikum Graz, KLinische Abteilung für Pulmonologie
Landeskrankenhaus-Universitätsklinikum Graz, KLinische Abteilung für Pulmonologie leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#81 Centro de Oncologia de Precision
Las Condes, Chile
Centro de Oncologia de Precision leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#82 Facultad Odontología Unipac
Santiago, Chile
Facultad Odontología Unipac leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#83 Klinički Bolnički Centar Osijek
Osijek, Croatia
Klinički Bolnički Centar Osijek leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#84 Klinicka Bolnica Centar - Sestre Milosrdnice - Klinika Za Tumore (University Hospital for Tumors)
Zagreb, Croatia
Klinicka Bolnica Centar - Sestre Milosrdnice - Klinika Za Tumore (University Hospital for Tumors) leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#85 Klinički Bolnički Centar Sestre Milosrdnice
Klinički Bolnički Centar Sestre Milosrdnice leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#86 High-tech Hospital Med Center
Batumi, Georgia
High-tech Hospital Med Center leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#87 High Technology Medical Center, University Clinic
Tbilisi, Georgia
High Technology Medical Center, University Clinic leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#88 Institute of Clinical Oncology
Institute of Clinical Oncology leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#89 Latvian Oncology Center
Riga, Latvia
Latvian Oncology Center leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#90 Paula Stradiņa Klīniskā Universitātes Slimnīca
Paula Stradiņa Klīniskā Universitātes Slimnīca leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#91 Hospital of Lithuanian University of Health Sciences Kauno Klinikos
Kaunas, Lithuania
Hospital of Lithuanian University of Health Sciences Kauno Klinikos leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#92 Nacionalinis Vezio Institutas
Vilnius, Lithuania
Nacionalinis Vezio Institutas leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#93 Hospital Tengku Ampuan Afzan
Kuantan, Malaysia
Hospital Tengku Ampuan Afzan leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#94 Hospital Umum Sarawak - Clinical Research Centre
Kuching, Malaysia
Hospital Umum Sarawak - Clinical Research Centre leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#95 Gleneagles Medical Centre - Penang
Pulau Pinang, Malaysia
Gleneagles Medical Centre - Penang leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#96 Hospital Garcia de Orta, EPE
Almada, Portugal
Hospital Garcia de Orta, EPE leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#97 Hospital CUF Descobertas
Lisbon, Portugal
Hospital CUF Descobertas leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#98 Hospital Lusíadas Lisboa
Hospital Lusíadas Lisboa leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#99 Centrul Medical Medicover Victoria
Bucharest, Romania
Centrul Medical Medicover Victoria leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#100 Spitalul Memorial Healthcare International
Spitalul Memorial Healthcare International leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#101 Onco Clinic Consult SA
Craiova, Romania
Onco Clinic Consult SA leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#102 Phramongkutklao Hospital
Bangkok, Thailand
Phramongkutklao Hospital leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#103 Faculty of Medicine Vajira Hospital
Dusit, Thailand
Faculty of Medicine Vajira Hospital leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#104 Prince of Songkhla University
Hat Yai, Thailand
Prince of Songkhla University leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#105 Research Site
Concepción, Peru
Research Site leads on Sponsor Fit / Competitor Exposure / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#106 Research Site
Gävle, Sweden
#107 Research Site
Hanoi, Vietnam
#108 Research Site
Ho Chi Minh City, Vietnam
#109 Kantonsspital St. Gallen
Sankt Gallen, Switzerland
5.3
Kantonsspital St. Gallen leads on Sponsor Fit / Execution Stability / Site Startup Speed, resulting in Tier 3 prioritization for feasibility shortlisting.
#110 Oncocentro APYS
Viña del Mar, Chile
5
Oncocentro APYS leads on Sponsor Fit / PI Capacity / Site Startup Speed, resulting in Tier 3 prioritization for feasibility shortlisting.
#111 Universitätsspital Basel
Basel, Switzerland
4.7
Universitätsspital Basel leads on Sponsor Fit / Execution Stability / Site Startup Speed, resulting in Tier 3 prioritization for feasibility shortlisting.
#112 Hong Kong United Oncology Centre
Hong Kong, Hong Kong
4.3
Hong Kong United Oncology Centre leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#113 Queen Mary Hospital
Queen Mary Hospital leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#114 The Chinese University of Hong Kong
Shatin, Hong Kong
The Chinese University of Hong Kong leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#115 Auckland City Hospital - Cancer and Blood Research
Grafton, New Zealand
Auckland City Hospital - Cancer and Blood Research leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#116 Pan American Center for Oncology Trials
San Juan, Puerto Rico
Pan American Center for Oncology Trials leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#117 National Cancer Centre Singapore
National Cancer Centre Singapore leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#118 Icon Cancer Centre
Icon Cancer Centre leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#119 North Estonia Medical Centre Foundation
Tallinn, Estonia
North Estonia Medical Centre Foundation leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#120 Tartu University Hospital
Tartu, Estonia
Tartu University Hospital leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#121 Pan American Oncology Trials, LLC
Pan American Oncology Trials, LLC leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#122 Auxilio Mutuo Cancer Center
Auxilio Mutuo Cancer Center leads on Sponsor Fit / Execution Stability / PI Capacity, resulting in Tier 3 prioritization for feasibility shortlisting.
#123 HFR Fribourg/Kantonsspital Fribourg
Fribourg, Switzerland
2.5
HFR Fribourg/Kantonsspital Fribourg leads on Sponsor Fit / Execution Stability / Site Startup Speed, resulting in Tier 3 prioritization for feasibility shortlisting.
Research Site
Seoul, South Korea · Tier: Tier 1
Total Score: 84.2
Why ranked high
startup median: 51 days
PI count: 9
matched profile count: 1
update log
2026-03-01 · v0.3.0
Live ClinicalTrials.gov Sync Connected